surmount-1 trial tirzepatide obesity without diabetes weight loss SURMOUNT 1 // Three-Year Obesty & Prevention Outcomes Weight reduction with different doses

Regular consultations and monitoring ensure continued effectiveness and safety throughout your Semaglutide journey

Neuroscience (1997) 77:25770

The Most Concerning Long-Term Risks of GLP-1 Drugs Below are the strongest areas of concern based on clinical observations, case reports, patient outcomes, and developing research

Footnotes Author Contributions: Conceptualization: CEE, LA, MFL, HCB & EJ

A few notes for non-traditional eating windows: If you fast until noon or later, take WLP-1 before your first meal of the day, not at sunrise If you eat a small breakfast and a bigger lunch, lunch may be the better target If you struggle most with afternoon cravings or evening overeating, you can split your dose: one in the morning, one in the early afternoon The goal isn't a clock

Step-by-step reconstitution protocol This protocol assumes you're adding 2 mL of bacteriostatic water to create a 2.5 mg/mL solution